Suchbegriffe: DOSE-RESPONSE RELATIONSHIP, DRUG - DRUG THERAPY , . Treffer: 19
DeVries, JH; Nattrass, M; Pieber, TR
Refining basal insulin therapy: what have we learned in the age of analogues?
DIABETES-METAB RES REV. 2007; 23(6): 441-454.
Doi: 10.1002/dmrr.762
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Heise, T; Pieber, TR
Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies.
DIABETES OBES METAB. 2007; 9(5): 648-659.
Doi: 10.1111/j.1463-1326.2007.00756.x
Web of Science
PubMed
FullText
FullText_MUG
Kann, PH; Wascher, T; Zackova, V; Moeller, J; Medding, J; Szocs, A; Mokan, M; Mrevlje, F; Regulski, M
Starting insulin therapy in type 2 diabetes: twice-daily biphasic insulin Aspart 30 plus metformin versus once-daily insulin glargine plus glimepiride.
Exp Clin Endocrinol Diabetes. 2006; 114(9):527-532
Doi: 10.1055/s-2006-949655
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Maas, AI; Murray, G; Henney, H; Kassem, N; Legrand, V; Mangelus, M; Muizelaar, JP; Stocchetti, N; Knoller, N; Pharmos TBI investigators
Efficacy and safety of dexanabinol in severe traumatic brain injury: results of a phase III randomised, placebo-controlled, clinical trial.
Lancet Neurol. 2006; 5(1): 38-45.
Doi: 10.1016/S1474-4422(05)70253-2
Web of Science
PubMed
FullText
FullText_MUG
Abciximab Emergent Stroke Treatment Trial (AbESTT) Investigators
Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.
Stroke. 2005; 36(4):880-890
Doi: 10.1161/01.STR.0000157668.39374.56
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Hrzenjak, A; Reicher, H; Wintersperger, A; Steinecker-Frohnwieser, B; Sedlmayr, P; Schmidt, H; Nakamura, T; Malle, E; Sattler, W
Inhibition of lung carcinoma cell growth by high density lipoprotein-associated alpha-tocopheryl-succinate.
CELL MOL LIFE SCI. 2004; 61(12): 1520-1531.
Doi: 10.1007/s00018-004-4101-4
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Hermann, J; Mueller, T; Fahrleitner, A; Dimai, HP
Early onset and effective inhibition of bone resorption in patients with rheumatoid arthritis treated with the tumour necrosis factor alpha antibody infliximab.
CLIN EXP RHEUMATOL 2003 21: 473-476.
Web of Science
PubMed
Mikosch, P; Obermayer-Pietsch, B; Jost, R; Jauk, B; Gallowitsch, HJ; Kresnik, E; Leb, G; Lind, P
Bone metabolism in patients with differentiated thyroid carcinoma receiving suppressive levothyroxine treatment.
Thyroid. 2003; 13(4):347-356
Doi: 10.1089/105072503321669839
Web of Science
PubMed
FullText
FullText_MUG
Panzenböck, U; Kritharides, L; Raftery, M; Rye, KA; Stocker, R
Oxidation of methionine residues to methionine sulfoxides does not decrease potential antiatherogenic properties of apolipoprotein A-I.
J Biol Chem. 2000; 275(26): 19536-19544.
Doi: 10.1074/jbc.M000458200
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
Stoschitzky, K; Klein, W
Beta blockers--1997 update
Wien Klin Wochenschr. 1997; 109(7):222-231
Web of Science
PubMed
Hollweg, M; Kapfhammer, HP
Paranoid psychosis after treatment with the antibiotic ofloxacin
Psychiatr Prax. 1996; 23(5):251-251
(- Case Report)
Web of Science
PubMed
Google Scholar
Fleischhacker, WW; Hinterhuber, H; Bauer, H; Pflug, B; Berner, P; Simhandl, C; Wolf, R; Gerlach, W; Jaklitsch, H; Sastre-y-Hernández, M
A multicenter double-blind study of three different doses of the new cAMP-phosphodiesterase inhibitor rolipram in patients with major depressive disorder.
Neuropsychobiology. 1992; 26(1-2):59-64
Doi: 10.1159/000118897
Web of Science
PubMed
FullText
FullText_MUG
Zeiss, J; Merrick, HW; Savolaine, ER; Woldenberg, LS; Kim, K; Schlembach, PJ
Fatty liver change as a result of hepatic artery infusion chemotherapy.
Am J Clin Oncol. 1990; 13(2):156-160
Doi: 10.1097/00000421-199004000-00013
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Schabus, V; Sixl, W; Sixl-Voigt, B; Marth, E; Köck, M
Ocular infection investigations in Cairo's waste disposal sites. PVP-iodine treatment trials.
Geogr Med Suppl. 1989; 3(4 Suppl): 103-112.
PubMed
Schmauss, M; Kapfhammer, HP; Meyr, P; Hoff, P
Combined MAO-inhibitor and tri- (tetra) cyclic antidepressant treatment in therapy resistant depression.
Prog Neuropsychopharmacol Biol Psychiatry. 1988; 12(4): 523-532.
Doi: 10.1016/0278-5846(88)90111-X
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
Zeichen, R; Stradner, F
Current diabetology--therapy with human insulin
Wien Med Wochenschr. 1985; 135(6-7):188-190
Web of Science
PubMed
Beaufort, F; Lammer, J; Stammberger, H
High-dose methylprednisolone in the treatment of terminal cancer patients
Wien Klin Wochenschr. 1984; 96(14):549-551
Web of Science
PubMed
Beaufort, F; Fereberger, W
High-dose gestagen therapy in breast cancer
Wien Med Wochenschr. 1983; 133(7):169-173
Web of Science
PubMed
Schenk, H; Fereberger, W
Gestagen therapy of breast cancer. Effect of high doses on the blood coagulation system
MMW Munch Med Wochenschr. 1983; 125(40):875-876
Web of Science
PubMed